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Figure	 2.	 Fluorescence	 microscopy	 images	 of:	 (a)	 HA;	 (b)	 HA	 coated	 with	 electrostatic	
coating,	 imaged	 immediately	 after	 washing	 following	 coating;	 (c)	 HA	 coated	 with	
electrostatic	coating,	after	samples	had	been	stored	in	simulated	body	fluid	for	one	month	
with	 changes	 every	 7	 days;	 (d	 )	 thiol-modified	 HA;	 (e)	 thiol-modified	 HA	 with	 covalent	
coating,	 imaged	 immediately	 after	 washing;	 (f	 )	 thiol-modified	 HA	 with	 covalent	 coating,	
after	samples	had	been	stored	in	simulated	body	fluid	for	one	month	with	changes	every	7	
days	before.	All	 images	are	representative	of	all	 sample	surfaces.	 (g)	Quantification	of	 the	
fluorescence	on	 the	 covalently	 coated,	 thiol-modified	HA	over	 time,	 showing	 the	 average	
surface	 pixel	 count,	 n	 .	 3,	 and	 error	 bars	 show	 the	 standard	 error	 of	 the	 mean.	 (h)	
Quantification	 of	 the	 fluorescence	 on	 the	 covalently	 coated,	 thiol-modified	 HA	 after	
treatment	with	 proteases,	 n	 .	 3,	 and	 error	 bars	 show	 the	 standard	 error	 of	 the	mean.	 (i)	






 Ca P C O Si S 
Hydroxyapatite 29.39	±	0.64 16.74	±	0.74 6.93	±	0.35 46.94	±	0.44 0	±	0 0	±	0 
Hydroxyapatite	–	
thiol	modified 
31.62	±	0.93 16.25	±	0.43 8.78	±	0.44 42.40	±	1.13 0.2	0	±	0.08 0.37	±	0.10 
Hydroxyapatite	
dAMP 




































Figure	4.	 (a)	The	number	of	 colony-forming	units	 found	on	cAMP–tHA,	dAMP–tHA	or	 tHA	
after	incubation	with	S.	aureus,	S.	epidermidis	and	P.	aeruginosa.	Error	bars	show	standard	
error	 of	 the	 mean,	 n	 =	 6,	 ***p<0.000.	 (b)	 The	 absorbance	 of	 the	 bacteria	 in	 broth	
surrounding	 the	 surface	 at	 600	 nm	 for	 S.	 epidermidis,	 S.	 aureus	 and	 P.	 aeruginosa	 in	 the	

























































Figure 7. (a) Osteoblast precursor cells grown on tissue culture plastic with and 
without AMP in the cell media throughout growth. (b) Osteosarcoma cells grown on 
tissue culture plastic with and without AMP in the cell media, n = 6, error bars show 
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